Herbal Medicine for Chronic Lung Conditions (NRICM102)
Part of Lungs & breathing clinical trials.
This trial tests an herbal medicine called NRICM102 for people with chronic cough and long-term lung diseases like asthma or COPD. It aims to see if the medicine is safe and helps improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have a long-term lower airway condition (like asthma, COPD, or lung fibrosis) diagnosed by a lung doctor
- Have had a chronic cough or cough with phlegm for at least 3 months while on your regular breathing medication
- Be willing to see a Traditional Chinese doctor to check if the study treatment (NRICM102) is right for you
- Not be pregnant or breastfeeding, and not have had a serious lung crisis needing ICU care in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding an experimental herbal medicine (NRICM102) to standard antibiotics can help adults hospitalized with community-acquired pneumonia recover faster. It is a phase 2 study, meaning the treatment is still being tested for safety and effectiveness.
This trial tests whether an extended-release medication called nalbuphine can reduce coughing in people with chronic cough that hasn't improved with other treatments. You may be eligible if you've had a persistent cough for at least a year and have already tried treatments for conditions that could cause it.
This 24-week study tests whether a new medicine called BLU-5937 can help adults whose chronic cough hasn't improved with standard treatments. Chronic cough that lasts a year or longer can seriously affect quality of life, and this trial explores whether this drug might provide relief.
This study is following people with asthma to learn how traditional Chinese medicine might help manage the condition. It is an observational study, so you will not receive a new treatment, but your health will be tracked over time.
This trial tests an investigational tablet for people with chronic lung diseases like bronchiectasis, COPD, or asthma who produce at least 10 mL of sputum (mucus coughed up from the lungs) each day. The goal is to see if the drug safely reduces excess airway mucus.
This study tests a new medicine for people with non-cystic fibrosis bronchiectasis. It aims to see if the drug can help reduce symptoms and improve quality of life.
Hear when a new Chronic Lower Respiratory Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.